Today: 21 May 2026
Browse Category

NYSE:UNH 21 January 2026 - 27 January 2026

Dow Jones tumbles as UnitedHealth rout drags blue chips while Fed looms

Dow Jones tumbles as UnitedHealth rout drags blue chips while Fed looms

The Dow Jones Industrial Average fell 408.99 points to 49,003.41, led by a nearly 20% plunge in UnitedHealth after the Trump administration proposed a smaller-than-expected Medicare Advantage rate hike. The S&P 500 rose 0.4% to a record high, while the Nasdaq gained 0.9%. General Motors advanced after strong earnings and a $6 billion buyback. Investors await the Federal Reserve’s rate decision Wednesday.
27 January 2026
··
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group shares fell 19.5% to $282.90 in after-hours trading Tuesday after a weak Medicare Advantage rate proposal from the Trump administration. The company expects to lose up to 1.4 million Medicare Advantage members in 2026 and forecasts a drop in Medicaid membership. CVS and Humana shares also plunged. The government’s final Medicare Advantage rate decision is due April 6.
27 January 2026
···
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
27 January 2026
···
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
27 January 2026
···
Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

S&P 500 and Nasdaq futures rose early Tuesday, while Dow futures slipped, weighed by UnitedHealth after Washington proposed keeping Medicare Advantage payments nearly flat for 2027. Insurers fell in premarket trading. Investors awaited earnings reports and the Federal Reserve’s policy decision due Wednesday. Salesforce shares gained on news of a $5.6 billion U.S. Army contract.
27 January 2026
···
Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow futures fell 40 points premarket Tuesday as UnitedHealth dropped 8.6% after a proposed Medicare Advantage rate increase came in far below expectations. S&P 500 and Nasdaq futures rose ahead of major earnings reports and the start of the Federal Reserve meeting. Salesforce gained 2.2% after landing a $5.6 billion U.S. Army contract. A partial government shutdown loomed with funding set to expire after midnight Friday.
27 January 2026
····
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
27 January 2026
··
UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth shares fell over 10% in after-hours trading Monday after U.S. officials proposed a 0.09% average payment increase for Medicare Advantage plans in 2027. The Centers for Medicare & Medicaid Services also outlined changes to risk adjustment, including limits on payments tied to certain chart reviews. CVS Health and Humana shares dropped as much as 15%. UnitedHealth reports earnings and 2026 guidance Tuesday morning.
27 January 2026
·
Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

The Dow Jones Industrial Average rose 185.35 points, or 0.38%, to 49,284.06 by 10:32 a.m. EST, led by gains in Apple and Cisco. UnitedHealth and Boeing slipped, limiting the advance. Gold surged past $5,100 an ounce, setting a new record. Investors await the Federal Reserve meeting starting Tuesday and a U.S. funding deadline on Jan. 30.
26 January 2026
·······
Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

The Health Care Select Sector SPDR Fund (XLV) fell 0.5% to $157.48 Friday, with Eli Lilly down 2.1%. Johnson & Johnson and UnitedHealth posted small gains. Traders are watching obesity-drug demand and a crowded earnings calendar next week. The FDA linked ByHeart’s recalled infant formula to a multi-state botulism outbreak.
25 January 2026
·····
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
24 January 2026
·····
UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth shares rose about 0.5% in after-hours trading Friday, closing at $356.26. The move followed CEO Stephen Hemsley’s announcement that the company will rebate profits from its Obamacare plans as Congress scrutinizes insurer practices. Lawmakers questioned UnitedHealth and other major insurers on Capitol Hill over rising costs. Investors await UnitedHealth’s earnings report and 2026 guidance on Jan. 27.
24 January 2026
·
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
23 January 2026
··
Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

UnitedHealth shares rose 1.96% to $354.47 Thursday as investors focused on the insurer’s plan to rebate ACA profits starting in 2026. CEO Stephen Hemsley faced lawmakers over rising insurance costs, while analysts await the company’s Jan. 27 results and 2026 outlook. ACA premiums are projected to more than double next year, with enrollment expected to fall by two-thirds.
22 January 2026
··
Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

The Dow Jones rose about 0.6% Wednesday, recovering nearly 297 points after President Trump ruled out using force to acquire Greenland. Tuesday saw the index plunge 870 points following new U.S. tariffs on European goods. Merck and UnitedHealth led early gains, while IBM and 3M dragged on the previous session. Investors await jobless claims data Thursday and the Fed meeting next week.
21 January 2026
······
Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

The Dow Jones rose 203 points to 48,692.15 early Wednesday, rebounding after Tuesday’s 870-point drop triggered by Trump’s tariff threats on eight European countries. Healthcare stocks led gains, with Merck and UnitedHealth adding about 40 points. The Supreme Court began hearing arguments on Trump’s bid to fire Fed Governor Lisa Cook. A Reuters poll showed economists expect the Fed to hold rates steady this quarter.
21 January 2026
·······
1 2 3 4 5 6 … 10

Stock Market Today

  • Planet Labs Nears Sustainable Profitability Amid Industry Challenges
    May 21, 2026, 3:12 PM EDT. Planet Labs (PL) operates a vast network of Earth observation satellites capturing global images daily. Despite technological advances and expanded roles in defense and agriculture, the company has yet to secure steady profits due to high costs in satellite manufacturing, launches, maintenance, and R&D. Revenue growth lags behind fixed costs, while long government sales cycles delay cash flow. Management's 2026 guidance shows optimism, focusing on cost control, vertical specialization, and software monetization to enhance margins. Industry peers Rocket Lab (RKLB) and BlackSky Technology (BKSY) face similar profitability challenges. PL's stock has surged 117% year-to-date but trades at a lofty price-to-sales ratio of 31.38, far above the industry average of 3.86, reflecting high investor expectations amid ongoing financial pressures.

Latest articles

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

21 May 2026
Nebius Group N.V. shares surged 15.6% to $221.72 after announcing a fuel cell power deal with Bloom Energy, securing up to 328 MW of on-site electricity capacity for its AI infrastructure. The agreement could cost Nebius up to $2.6 billion over 10 years. Bloom shares rose 12.2% on the news. Nebius's first-quarter revenue jumped to $399 million from $50.9 million a year earlier.
Sirius XM stock nears new highs as traders look at audio strategy

Sirius XM stock nears new highs as traders look at audio strategy

21 May 2026
Sirius XM shares rose 6.8% to $28.90 by 2:07 p.m. EDT Thursday, outpacing major U.S. indexes. The rally followed CFO Zac Coughlin’s investor conference appearance and news of a renewed multi-year NASCAR broadcast deal. First-quarter subscriber losses were smaller than expected, and revenue topped forecasts. Volume reached 4.8 million shares, with a market value near $9.8 billion.
KEEL Surges as Investors Back Keel’s AI Data Center Plans

KEEL Surges as Investors Back Keel’s AI Data Center Plans

21 May 2026
Keel Infrastructure shares jumped 7.1% to $4.53 Thursday, nearing a 52-week high, as investors bet on its pivot from crypto mining to AI-focused power infrastructure. Trading volume reached 22.31 million shares, below average. The company reported a wider net loss of $145.35 million for the March quarter on lower revenue and warned its transformation faces risks tied to permits, costs, and competition.
Go toTop